Hyderabad: India is a step closer to getting the first naval COVID-19 vaccine.
Clinical phase 3 trials of Bharat Biotech’s COVID-19 nasal vaccine have been completed, and the Hyderabad-based company will soon be submitting its data to Drugs Controller General of India (DCGI) next month.
“We just completed a clinical trial, a data analysis is going on. Next month, we will submit the data to the regulatory agency. If everything is okay, then we will get permission to launch and it will be the world’s first clinically proven nasal COVID-19 vaccine,” Bharat Biotech Chairman and MD Dr Krishna Ella told ANI.
DCGI had granted permission to Bharat Biotech to conduct standalone phase 3 trials in January.
Dr Ella was in Paris as a speaker at Viva Technology 2022, where India was declared country of the year.
“I am glad to say 65 startups from India, under NITI Aayog they all came, showing that technology to a lot of people, what India can do, how India can innovate for the world. They are vibrant because I was a startup in 1997,” Dr Ella said.
Bhubaneswar: The Central Bureau of Investigation (CBI) has arrested Divisional Railway Manager (Waltair Division), Visakhapatnam,…
Bhunbaneswar: Vigilance sleuths on Monday launched simultaneous raids at four places linked to Subash Chandra…
Bhubaneswar: The 10th National Children’s Literary Festival 2024 at KIIT International School began on a…
Bhubaneswar: Dr Achyuta Samanta, the Founder of KIIT and KISS, has been conferred the prestigious…
Sambalpur: In a tragic incident, three elephants died reportedly due to electrocution after coming in…
New Delhi: Amid reports that Ayatollah Ali Khamenei is seriously ill, the Iranian supreme leader…
New Delhi: The air pollution level in the national capital reached the ‘severe plus’ category…
Why Chilika's Irrawaddy dolphin population matters On the surface, the Irrawaddy dolphin appears to be…